Current Interview: Professor Nikolaus Rajewsky, Director of the Berlin Institute for Medical Systems Biology at the Max Delbrück Center for Molecular Medicine in Berlin

Nikolaus Rajewsky studied mathematics and physics in his hometown of Cologne. After earning his doctorate, he spent time abroad in New Jersey and New York. In 2006, the 50-year-old returned to Germany and has since been Professor of Systems Biology...

More

Digital Health Summit Berlin

More

Adrenomed closes € 24 M financing led by Wellington and HBM

  • The financing round was led by top-tier life science venture capitalists Wellington Partners and HBM Healthcare Investments, joined by existing shareholders
  • The new funds will be used to execute a proof-of-concept clinical program of lead product...
More

Call for Abstracts: 2nd German Mass Cytometry User Forum in Berlin

Extended deadline for abstract submissions: November 28, 2018

More

Ipsen and 3BP announce First Patient Dosed in Phase I/II study for first-in-class radionuclide

Ipsen (Euronext: IPN; ADR: IPSEY) and 3BP today announced the first patient has been dosed in a Phase I/II study for the first-in-class radionuclide 177Lu-IPN01087 (formerly known as 3BP-227). IPN01087 is a compound that targets cancer cells in...

More

Eckert & Ziegler Q3/2018: Increase in Revenue in all Business Segments

Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in isotope-related applications in medicine, science and industry, increased the earnings per share to €2.50 in the third quarter of 2018 and thus reached...

More

NOXXON announces EUR 6.2 million equity capital raise including US$ 5 million from US family office - Acuitas Capital, LLC

NOXXON ends the use of variable rate equity financing with Yorkville

More

TU Berlin: In focus: Peptides, the “little brothers and sisters” of proteins

A new Research Training Group aims to decode the complex structure of peptides. The German Research Foundation is to provide EUR 4.5 million in funding for the research

More

Revolutionizing the production of novel diagnostics with cost-effective Roll-to-Roll imprinting

R2R Biofluidics EU project recently received the Austrian Fast Forward Award 2018

More

OMEICOS Therapeutics Closes €17m Series C Financing to Advance Lead Candidate OMT-28 Towards Pivotal Trials in Atrial Fibrillation

Proceeds provide OMEICOS with the financial runway to conduct the Phase II Study PROMISE-AF and continue expansion into ophthalmology through US subsidiary

More
Show more items